These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3032804)

  • 1. The development of a new agent for the treatment of inflammatory/allergic conditions.
    Cairns H; Orr TS
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):513-7. PubMed ID: 3032804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway constriction by isocapnic hyperventilation of cold, dry air: comparison of magnitude and duration of protection by nedocromil sodium and sodium cromoglycate.
    Juniper EF; Kline PA; Morris MM; Hargreave FE
    Clin Allergy; 1987 Nov; 17(6):523-8. PubMed ID: 2830047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey.
    Eady RP; Greenwood B; Jackson DM; Orr TS; Wells E
    Br J Pharmacol; 1985 Jun; 85(2):323-5. PubMed ID: 2992657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of nedocromil sodium.
    Eady RP
    Eur J Respir Dis Suppl; 1986; 147():112-9. PubMed ID: 2429854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.
    Wells E; Jackson CG; Harper ST; Mann J; Eady RP
    J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monkeys infected with Ascaris suum (a new in vivo model of airway disease): protective effect of nedocromil sodium and sodium cromoglycate against bronchial antigen challenge.
    Jackson DM; Eady RP
    Eur J Respir Dis Suppl; 1986; 147():202-5. PubMed ID: 3021491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments.
    Leung KB; Flint KC; Brostoff J; Hudspith BN; Johnson NM; Pearce FL
    Eur J Respir Dis Suppl; 1986; 147():223-6. PubMed ID: 2429855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat.
    Riley PA; Mather ME; Keogh RW; Eady RP
    Int Arch Allergy Appl Immunol; 1987; 82(1):108-10. PubMed ID: 3026967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease.
    Gonzalez JP; Brogden RN
    Drugs; 1987 Nov; 34(5):560-77. PubMed ID: 2826101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma.
    Shaw RJ; Kay AB
    Br J Dis Chest; 1985 Oct; 79(4):385-9. PubMed ID: 2996580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease.
    Lal S; Dorow PD; Venho KK; Chatterjee SS
    Chest; 1993 Aug; 104(2):438-47. PubMed ID: 8393398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment?
    Schwartz HJ; Blumenthal M; Brady R; Braun S; Lockey R; Myers D; Mansfield L; Mullarkey M; Owens G; Ratner P; Repsher L; van As A
    Chest; 1996 Apr; 109(4):945-52. PubMed ID: 8635375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of nedocromil sodium and cromolyn sodium on antigen-induced responses in allergic sheep in vivo and in vitro.
    Abraham WM; Stevenson JS; Chapman GA; Tallent MW; Jackowski J
    Chest; 1987 Nov; 92(5):913-7. PubMed ID: 2822361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulised sodium cromoglycate in the preschool wheezy child.
    Lenney W; Milner AD
    Arch Dis Child; 1978 Jun; 53(6):474-6. PubMed ID: 99089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine-induced bronchoconstriction: comparison between nedocromil sodium and sodium cromoglycate.
    Crimi N; Palermo F; Oliveri R; Cacopardo B; Vancheri C; Mistretta A
    Eur J Respir Dis Suppl; 1986; 147():258-62. PubMed ID: 3021497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postgraduate course presentation. Cromolyn sodium in the treatment of asthma: changing concepts.
    Bernstein IL
    J Allergy Clin Immunol; 1981 Oct; 68(4):247-53. PubMed ID: 6169751
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical development of a new agent for the treatment of airway inflammation, nedocromil sodium (Tilade).
    Auty RM
    Eur J Respir Dis Suppl; 1986; 147():120-31. PubMed ID: 3021486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of nedocromil sodium in asthma.
    Holgate ST
    Eur J Respir Dis Suppl; 1986; 147():149-59. PubMed ID: 3021489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obstructive airway diseases and their management using dinatrium cromoglicicum].
    Anolick GP; Schmidt OP; Primer G
    Med Klin; 1975 Aug; 70(32-33):1290-5. PubMed ID: 818491
    [No Abstract]   [Full Text] [Related]  

  • 20. The preventive effect and duration of action of nedocromil sodium and cromolyn sodium on exercise-induced asthma (EIA) in adults.
    König P; Hordvik NL; Kreutz C
    J Allergy Clin Immunol; 1987 Jan; 79(1):64-8. PubMed ID: 3027153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.